Published in Med Microbiol Immunol on August 29, 2002
Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol (2009) 1.03
Detection of herpesvirus EBV DNA in the lower respiratory tract of ICU patients: a marker of infection of the lower respiratory tract? Med Microbiol Immunol (2013) 0.79
Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection. Infection (1991) 3.29
Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol (2000) 1.39
Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerase chain reaction and subsequent restriction fragment length polymorphism analysis. Zentralbl Bakteriol (1994) 1.03
Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Med Microbiol Immunol (2002) 1.02
Kaposi's sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems. Med Microbiol Immunol (2001) 0.96
[Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox]. Dtsch Med Wochenschr (2001) 0.94
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol (2003) 4.66
Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain. Clin Chem (2006) 2.32
Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol (2009) 1.65
Phylogeny of the SARS coronavirus. Science (2003) 1.56
Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra. J Clin Microbiol (2002) 1.42
Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression. FEMS Microbiol Rev (2004) 1.40
Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence. Trends Microbiol (2003) 1.39
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med (2006) 1.34
Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3. Cancer Res (2009) 1.34
Histone deacetylase inhibitors suppress natural killer cell cytolytic activity. FEBS Lett (2007) 1.20
Severe acute respiratory syndrome: identification of the etiological agent. Trends Mol Med (2003) 1.13
Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model. Int J Cancer (2003) 1.12
Valproic acid as anti-cancer drug. Curr Pharm Des (2007) 1.11
Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J Antimicrob Chemother (2007) 1.11
Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology. Trends Mol Med (2004) 1.11
Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students. Med Microbiol Immunol (2007) 1.10
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines. Biochem Pharmacol (2009) 1.09
Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. J Virol (2005) 1.08
SARS molecular detection external quality assurance. Emerg Infect Dis (2004) 1.08
Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression. PLoS One (2011) 1.06
Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression. J Infect Dis (2002) 1.05
Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein. J Virol (2004) 1.03
Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol (2009) 1.03
First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion (2009) 1.02
Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma. Cancer Res (2003) 0.99
Molecular assays for monitoring HIV infection and antiretroviral therapy. Expert Rev Mol Diagn (2007) 0.98
Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells. Neoplasia (2010) 0.97
Comparison of nine resistance interpretation systems for HIV-1 genotyping. Antivir Ther (2003) 0.96
Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies. Virology (2007) 0.95
Novel approach for genotyping varicella-zoster virus strains from Germany. J Clin Microbiol (2007) 0.95
Infection of human retinal pigment epithelial cells with influenza A viruses. Invest Ophthalmol Vis Sci (2009) 0.94
West Nile virus infection induces interferon signalling in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2006) 0.93
Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo. Int J Oncol (2006) 0.93
NK sensitivity of neuroblastoma cells determined by a highly sensitive coupled luminescent method. Biochem Biophys Res Commun (2005) 0.92
Oncomodulation by human cytomegalovirus: evidence becomes stronger. Med Microbiol Immunol (2009) 0.92
Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasiveness. Neoplasia (2004) 0.92
Oncomodulation by human cytomegalovirus: novel clinical findings open new roads. Med Microbiol Immunol (2010) 0.91
Multimutated herpes simplex virus g207 is a potent inhibitor of angiogenesis. Neoplasia (2005) 0.91
Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg. J Clin Microbiol (2003) 0.91
Evaluation of the LiPA HIV-1 RT assay version 1: comparison of sequence and hybridization based genotyping systems. J Clin Virol (2002) 0.91
Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus. Med Microbiol Immunol (2009) 0.91
Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition. Invest Ophthalmol Vis Sci (2005) 0.90
HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochem Biophys Res Commun (2004) 0.90
The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication. Cell Mol Life Sci (2010) 0.90
Prevalence- and gender-specific immune response to opportunistic infections in HIV-infected patients in Lesotho. Sex Transm Dis (2010) 0.89
HBV reactivation after kidney transplantation. J Clin Virol (2005) 0.89
Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells. Neoplasia (2008) 0.89
Expression level of neural cell adhesion molecule (NCAM) inversely correlates with the ability of neuroblastoma cells to adhere to endothelium in vitro. Cell Commun Adhes (2003) 0.88
Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D. J Clin Microbiol (2007) 0.88
Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame. PLoS One (2012) 0.87
Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. J Med Chem (2006) 0.87
Role of interferons in the treatment of severe acute respiratory syndrome. Expert Opin Biol Ther (2004) 0.86
Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation. Med Res Rev (2005) 0.86
Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells. Med Microbiol Immunol (2009) 0.86
Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine (2010) 0.86
Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid. Biochem Pharmacol (2004) 0.85
Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Res (2005) 0.85
Detection and quantitation of HBV DNA in miniaturized samples: multi centre study to evaluate the performance of the COBAS ® AmpliPrep/COBAS ® TaqMan ® hepatitis B virus (HBV) test v2.0 by the use of plasma or serum specimens. J Virol Methods (2010) 0.84
Impact of persistent cytomegalovirus infection on human neuroblastoma cell gene expression. Biochem Biophys Res Commun (2005) 0.84
Problems and challenges in the diagnosis of vertical infection with human cytomegalovirus (CMV): lessons from two accidental cases. J Clin Virol (2011) 0.84
Of chickens and men: avian influenza in humans. Curr Mol Med (2009) 0.84
Evaluation of the new ARCHITECT anti-HCV screening test under routine laboratory conditions. J Clin Virol (2008) 0.84
In vitro replication of varicella-zoster virus in human retinal pigment epithelial cells. J Clin Microbiol (2008) 0.83
[Varicella and herpes zoster. Part 1: virology, epidemiology, clinical picture, laboratory diagnostics]. Med Klin (Munich) (2010) 0.83
A novel immunomodulatory mechanism of ribavirin in suppressing natural killer cell function. Biochem Pharmacol (2009) 0.83
High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells. Int J Mol Med (2005) 0.82
A 10-year molecular survey of herpes simplex virus type 1 in Germany demonstrates a stable and high prevalence of genotypes A and B. J Clin Virol (2009) 0.82
Quadruple nucleoside therapy with zidovudine, lamivudine, abacavir and tenofovir in the treatment of HIV. Antivir Ther (2007) 0.81
Novel approach to differentiate subclades of varicella-zoster virus genotypes E1 and E2 in Germany. Virus Res (2009) 0.81
The human eye (retina): a site of persistent HCMV infection? Graefes Arch Clin Exp Ophthalmol (2005) 0.81
Ribavirin inhibits angiogenesis by tetrahydrobiopterin depletion. FASEB J (2006) 0.81
3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells. Biochem Pharmacol (2002) 0.80
Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation. J Clin Virol (2005) 0.80
Effects of S-acetylglutathione in cell and animal model of herpes simplex virus type 1 infection. Med Microbiol Immunol (2003) 0.80
Thrombin stimulates IL-6 and IL-8 expression in cytomegalovirus-infected human retinal pigment epithelial cells. Int J Mol Med (2004) 0.80
The anti-tumoral drug enzastaurin inhibits natural killer cell cytotoxicity via activation of glycogen synthase kinase-3β. Biochem Pharmacol (2010) 0.79
Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells. Cardiovasc Res (2007) 0.79
Dengue in travellers is still underestimated. Intervirology (2008) 0.79
Phytochemical analysis and in vitro evaluation of the biological activity against herpes simplex virus type 1 (HSV-1) of Cedrus libani A. Rich. Phytomedicine (2007) 0.78
[Viral gastroenteritis. An epidemiologic investigation between the period 2001-2006]. Med Klin (Munich) (2008) 0.78
Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages. Med Microbiol Immunol (2010) 0.78
Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species. Chem Biodivers (2008) 0.78
Thrombin induces Sp1-mediated antiviral effects in cytomegalovirus-infected human retinal pigment epithelial cells. Med Microbiol Immunol (2003) 0.78
Molecular analysis of varicella-zoster virus strains circulating in Tanzania demonstrating the presence of genotype M1. J Clin Microbiol (2008) 0.77
A 12-year molecular survey of clinical herpes simplex virus type 2 isolates demonstrates the circulation of clade A and B strains in Germany. J Clin Virol (2010) 0.77
Flow cytometric analysis of virus-specific T lymphocytes: practicability of detection of HCMV-specific T lymphocytes in whole blood in patients after stem cell transplantation. J Immunol Methods (2006) 0.77
Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J Ethnopharmacol (2008) 0.77
Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis. Med Microbiol Immunol (2012) 0.77
Evaluation of carcinogenic potential of two nitro-musk derivatives, musk xylene and musk tibetene in a host-mediated in vivo/in vitro assay system. Anticancer Res (2003) 0.77
[Varicella and herpes zoster. Part 2: therapy and prevention]. Med Klin (Munich) (2010) 0.76
Immune response after a single dose of the 2010/11 trivalent, seasonal influenza vaccine in HIV-1-infected patients and healthy controls. HIV Clin Trials (2013) 0.75
In vitro antiviral activity of aphidicolin and its derivates. Synergistic effects of aphidicolin with other antiviral drugs. Arzneimittelforschung (2002) 0.75